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Summary: We studied insulin binding to human erythrocytes usingtwo different 125I-insulin-tracers. Erythro-
cytes of 8 normal subjects were examined üsiftg [mono-I25I-(Tyr A 14)]insulin äs tracer. Three of these
efythrocyte preparations were examined simultaneously using [125I]insulin, which was randomly iodinated by
the chloramine-T-method.
Data were analysed by a computerized non-linear least-squares procedure both on the basis of one and two
class receptor models. Only the one class receptor fnodel yielded consistent results. When the two class
receptor model was applied the low affinity branch of the Scatchard plot was not reproducible. On the basis of
the one class receptor model the number of receptor sites was lower (Ro = 0.046 ± 0.006 nmol/1 equivalent to
6.3 ± 0.8 receptors/efythrocyte) with [mono-I?5I-(Tyr A 14)]insulin äs compared to [125I]insulin randomly
iodinated by the chloramine-T method (R0 s? 0.070 ± 0.008 iimol/1 equivalent to 9.6 ± 1.1 receptors/ery-
throcyte). Cönversely, the affinity of the [monoT125I-(Tyr A 14)]insülin was higher (Ka = 2.6 ± 0.3 x 109 l ·
mol"1 vs. 1.9 ± 0.2 109 l
Der Einfluß des Tracers auf die Insulinbindung an Erythrocyten des Menschen
Zusammenfassung: Die Insulinbindung an Human-Erythrocyten wurde mit zwei verschiedenen [125I]Insulin-
präparaten gemessen. Die Erythrocytenfezeptoren von 8 Normalpersonen wurden mit [Mono-I25I-(Tyr A
14)ilnsulin als Tracer bestimmt. Drei dieser Erythrocytenpräparationen wurden gleichzeitig mit [125I]Insulin,
das nach der Chloramm-T Methode hergestellt war, auf ihre Insulinbindüng untersucht.
Die Meßdaten wurden mit Hilfe eines Computerprogramms nach einer nicht-linearen Regression ausge-
wertet; dabei wurden sowohl eine Bindungsklasse als auch zwei Bindungsklassen zu Grunde gelegt. Nur das
einklassige Bindungsmodell lieferte zuverlässige Werte. Bei Annahme eines zweiklassigeii Bindungsmodells
ergaben sich für den niederaffinen Bindungsast in der Scatchard Auftragung keine zuverlässigen Werte. Die
Auswertung nach dem einklassigen Bindungsmodell ergab mit [Mono-125I-(Tyr A 14)]Insulin als Tracer eine
niedrigere Rezeptorzahl (R0 = 0,046 ± 0,006 nmol/I entsprechend 6,3 ± 0,8 Rezeptoren/Erythrocyt) vergli-
chen mit [I25I]Insulin, iodiert nach der Chloramin-T-Methode (R0 = 0,070 ± 0,008 nmol/1 entsprechend 9,6
± 1,1 Rezeptoren/Erythrocyt). Umgekehrt war die Affinität des [MonoJ25I-(Tyr A 14)]Insulin höher (Ka =
2,6 ± 0,3 x 109 l - mor1 vs. 1,9 ± 0,2 x 109 l
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Introduction
Insulin binding studies to human erythrocytes have
been widely used since they were first described by
Cambhir et al. (1). The obtained data were usually
presented s displacement curves and Scatchard
plots.
The Scatchard plots described were often curvilinear
and there was an argument in the literature s to the
reason for this shape. Different concepts are under
discussion. Kahn et al. (2) suggested two populations
of receptors whereas De Meyts et al. (3) attributed
the curvilinear nature of the Scatchard plot to nega-
tive cooperativity between homogenous receptor
sites. In some cases the second class could be ex-
plained s an artifact due to an incorrectly determl·
nated unspecific binding (4).
To our knowledge only one of the authors (5) study-
ing insulin binding to erythrocytes has so far consi-
dered the influence of their tracers on their results.
We therefore st idied insulin binding to human ery-
throcytes using two different [125I]insulin-tracers.
[Mono-125I-(Tyr A 14)]insulin (Novo Research In-
stitute) is a purified isomer which is excl sively iodi-
nated in the Tyr A 14 position. In contrast [125I]in-
sulin labelled by the chloramine-T method is a mix-
ture of isomers (e.g. Tyr A 14, Tyr A 19, etc.) and
contains diiodinated tyrosines s well (6).
Materials and Methods
Blood (10-20 ml) was taken from 8 metabolically healthy volun-
teers after an overnight fast.
Novo Research Institute: 1. Porcine [mono-l25I-(Tyr A 14)insu-
lin, spec. radioactivity 6.77 MBqy^g, 2. Porcine mono-component
insulin.
Hoechst AG, Frankfurt, West Germany: Porcine [1?5I]insulin,
spec. radioactivity 5.55 MBq^g.
Merck AG, Darmstadt, West Germany: Hepes(N-2-hydroxy-
ethylpiperazine-N'-2-ethanesulphonic acid), MgCl2, CaCl2, dex-
trose, NaCl, tris (tris(hydroxymethylaminomethane)), KC1.
Fluka AG, Buchs SG, Switzerland: EDTA.
Serva Feinbiochemica, Heidelberg, West Germany: Bovine serum
albumin.
W & R Baiston Ltd: Whatman l PS filter.
Schuchardt, D-8010 Hohenbrunn, West Germany: Dibutyl
phthalate.
Beckman: Microfuge B
Sorvall: Superspeed RC 2 B
BeVthold: LB MAG 510 gamma counter
Coulter: cell counter
Assay Buffer. Our assay buffer was buffer G s described by
Cambhir et al. (1), except that we used 10 g/l bovirie serum al-
bumin.
Preparation of erythrocytes
The erythrocytes were separated by a method described by
Beutler et l. (7), with some minor modifications.
Blood was collected into heparinized tubes, passed through a co-
lumn of microcrystalline cellulose mixed 1:1 with alpha-cellulose
in 9 g/l saline. The number of red blood cells was counted in a
coulter counter. The erythrocytes were then rwastied three times
(400 g, 10 min, 4°C), first with 9 g/l saline, then with buffer G
without bovine serum albumin and last with buffer G containing
bovine serum albumin. Finally, the erythrocytes were resus-
pended to a concentration of 3.5 to 5.5 x 1012/1. Both before and
after the preparation red blood cells, reticulocytes and leukocytes
were counted. Leukocyte counts were always in the r nge of a cell
free control solution.
Blood glucose and serum insulin concentrations were determined
routinely.
Binding studies
Binding studies were pefformed s described elsewhere (1), with
some minor.modifications.
Briefly, 400 μΐ cell Suspension, 13.3 pm l/l or 50 pmol/1 125I la-
belled insulin and various amounts of unlabelled insulin (0^1
μιηοΐ/ΐ) in a total volume of 500 μΐ were incubated at 15 °C for
210 minutes.
After incubation, 150 μΐ aliquots were trarisfered to three chilled
microfuge tubes that contained 150 μΐ buffer G and 100 μΐ dibutyl
phthalate. After centrifugation, the tubes were kept in a refrigera-
tor at -80 °C for 30 minutes. The tips of the tufces containig the
cell pellets were then cut and radioactivity was counted in a gaifh-
ma counter.
Data analysis
Data were analyzed by a Computerized weighted nonlinear least^
sq ares procedure sing the displacement curves (4). Both one
class and two class receptor models were applied. Data are pfes=
ented in two ways.
Firstly, speeific binding of insulin is plotted s a function of the
logarithm of total insulin concentration. Noh-specific binding was
defined s [1?5I]insuIin binding in the. pr^esence of l μπιοίλ unla^
belled insuliri. This value was varied during the regression analysis
and small differences appeared depending on the assumption of
the one or two classes of toinding sites. The amount of insujin sper
cifically bound was normalized to a red cell concentration of 4.4 x
1012A
Secondly, the bound to free ratio (B/F) of insulin is plotted s a
function of bound insulin (B) using the results of the best fit (Seal·
chard plot). The number of receptor sites per cell was calc lated
on the basis of a one class model.
Results
Speeific insulin binding
Speeific insulin binding at 13.3 prnol/1 frnono-125!-
(Tyr A 14)]insulin varied from 0.09 to 0.13 (n = 20,
mean ± SD = 0.116 ± 0.012) in normal subjects
(fig. 1).
Speeific insulin binding at the same concentration of
randomly labelled [I25l]insulin was found to be
higher when examined simultaneously in three
healthy subjects (n = 6, double as^ays, mean ± SD
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= 0.119 ± 0.013 vs. 0.107 ± 0.015, fig. 2). Both
healthy and diabetic subjects showed reproducible
results with [mono-I25I-(Tyr A 14)]insulin, even in
diabetic patients with extremely low binding activity
(fig. 3).
Analys is of displacement curves
One class receptor model
On direct comparison we found that [mono-I25I-(Tyr
A 14)] insulin detected a lower number of receptor
0.01 0.1 l 10 100 1000
Total insulin concentration [nmol/U
Fig. 1. Fraction of [mono-125I-(Tyr A 14)]insulin specifically
bound t human erythrocytes is plotted against the con-
centration of insulin. Blood was taken from 8 healthy sub-
jects, 20—35 years old. A total of 20 experiments were
carried out. Nonspecific binding was defined s the ra-
dioactivity. measured in the cell pellet in the presence of l
μτηοΐ/ΐ native insulin. The results were normalized to a red
cell concentration of 4.4 x 10I2/1. Each ,point is the mean
of 20 experiments + l SD.
0.1 T 10 100
Total insulin concentration [nrnql/O
1000
Fig. 2. Insulin binding to the erythrocytes of 3 normal subjects.
Circles represent data obtained with [mono-125I-(Tyr A
14)]insulin, triangles stand for conventional [I25I]insulin.
The best fit curves are shown for either group assuming an
one class model.
sites (Ro = 0.046 ± 0.006 nmol/1) but showed a
higher affinity (Ka = 2.6 ± 0.3 χ 109 l · mol"1) than
randomly labelled [I25I]insulin (R0 = 0.070 ± 0.008
nmol/1; Ka = 1.9 ± 0.2 x 109 l · mor1; fig. 4). The













Fig. 3. Reproducibility of the measured specifically bound [mo-
no-125I-(Tyr A 14)]insulin.
A) data of a 25 year old healthy male, who was examined
7 times on 4 different days over a period of 4 months.
B) data of a 20 year old diabetic female with extremely
low insulin binding. She was examined 7 times under the







Fig. 4. Presentation of the binding data according to Scatchard
calculated with the nonlinear regression method using the
one-class receptor model. Circlcs represent data obtained
with [mono-l25I-(Tyr A 14)|insulin, triangles stand for
conventional |125l]insulin. Data are from the experiments
shown in figure 2.
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Two class receptor model
When the two class receptor model was applied (fig.
5) the low affinity part of the plot was not reproduci-
ble. In the same individuals under identical condi-
tions its intercept with the abscissa, and thus the





Fig. 5. Scatchard plots on the basis of the two-class receptor mod-
el. Same data äs in figure 2.
0.15 -
0,05
Bound insulin [nmol/ l]
0.1
Fig. 6. Scatchard plots of a healthy volunteer. Assays were per-
formed in duplicate and [mono-125I-(Tyr A 14)]insuiin
was used. The continuous lines were calculated on the ba-
sis of the one-class receptor model, the broken lines fepre-
sent the two-class receptor model. The low affinity
brahches of the Scatchard plots were not reproducible.
Discussion
Insulin binding studies to erythrocytes have been
used in clinical trials throughout the world over re-
cent years (5, 8, 9, 10, 11). Unfortunately the au-
thors used labelled insulin of different origin and
quality. So far only one gföup has CQnsidered the in-
fluence of the quality of their tracers on the binding
data (5).
In this study (5), the values given for the high affinity
binding constants (a 50-fold difference between the
two tracers) and for the high affinity binding sites
(210—230 receptofs/erythrocyte) are quite differeiit
from the values fourid in the present study, and those
found by others (11-14).
We could deinonstrate that the quality of the träcef
has a strong influence on the fesults, but in contrast
to the study by Schlüter et al. (5), the diffefeiices of
the affinity constants and receptor numbers äfe
much smaller. We cän explain these differences äs
observed in our experiments by different degrees of
purity of tracers. The chloramine-T-method, which
is commonly used to iodinate insulin, produces 4 iso-
mers (Tyr A 14, Tyr A 19, Tyr B 16 and Tyr B 26) äs
well äs diiodinated tyrosines.
These ispmers have different affinities to the insulin
receptor. The better these isomers ean be separated
and purified the fnore reliable will be the results
(15). Different methods used by the manufäcturers
to determine specific radioactivity may be another
explanation. Certäinly i t is fecommendable to use
only freshly labeljed insulin äs tracers, since the rate
of decay of the binding activity'may not closely cor-
relate with the rate of decreasing radioactivity. In
our study, the low affinity part of the Scatchard plot
was not reproducible with both tracers. We regärd
this äs an argument against the two class receptor
concept.
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